Skip to Main Content


  • Cannvocate posted an article
    Ensuring your SMS marketing platform as a Cannabis Business. see more

    By:  Emily Tuttle – Springbig  

    10DLC stands for 10-digit long code which are numbers that can support the high volume of text messages that successful A2P, or application-to-person, messaging requires. It offers delivery reliability and security for business senders by requiring campaign registrations from the companies, cutting down on campaign approval times and increasing deliverability.


    Increasing regulations

    All messaging traffic for major carriers like AT&T, Sprint, and T-mobile needs to be fully vetted and approved for 10DLC. Verizon launched its version of 10DLC in early 2020 but did not require a vetting process – just an increase in filtering for spam, scams, and unauthorized content related to SHAFT (Sex, Hate, Alcohol, Firearms, and Tobacco), whcih includes cannabis content.

    Now the cost of non-compliance is increasing which affects the cannabis industry directly. Wireless carriers have always enforced regulations like SHAFT guidelines for text message marketing but now the regulations are getting stricter and fees are higher for those who don’t comply with these regulations. We believe this makes it even more attractive than before to keep your communications compliant with regulations!

    These regulations are why after 10DLC was implemented, if your text message copy contained cannabis content you may have seen a gradual drop in Verizon deliverability as your messages might have been subject to some level of filtering. Also, in 2021 carriers such as T-Mobile announced that they would be heavily increasing fees on non-compliant messages. These include a pass-through fee of up to $10,000. As 10DLC becomes more prevalent, so do the regulations and fees concerning non-compliance. By not complying you are risking significant additional fees to your campaigns.

    That being said, using mass text message marketing is still very much possible for any cannabis dispensary, and from the perspective of sustainable business growth complying with 10DLC is the right call.


    Navigating 10DLC guidelines

    As it seems 10DLC is here to stay, here are a few tips on how to navigate the new rules while staying compliant:

    By ensuring your SMS marketing platform complies with the 10DLC regulations to avoid any unwanted fees. Using evasion techniques such as dynamic routing (gray routing) to go around 10DLC regulations can come with severe sanctions. In a heavily regulated field like the cannabis industry compliance is key, so avoid using platforms that try to evade regulations. Taking risks by not complying can hurt your business in the long run Including links in your copy that direct customers to websites can be a great way to provide customers with more information about for example upcoming events or products. However, make sure that the links landing page is also compliant with the guidelines, instead of sending links directly to cannabis websites.


    To learn more or see a demo of our industry leading platform please visit us at

  • Andrew Mullins posted an article
    MoCann's Heath Education & Training Committee Analyzes Recent Research on COVID Treatment with CBD see more

    Research Analysis by: Dr. Trish Hurford, MD, MS & Cindy Northcutt, RN, BSN, JD Co-Chairs,

    MoCannTrade Health, Education & Training Committee  


    Researchers from Oregon State University and the Oregon Health & Science University reported this month that CBDA and CBGA inhibited the reproduction and spread of the Covid-19 coronavirus. These products come from the raw cannabis plant. Could there be even more to the cannabis plant and its effects on health? The answer is, maybe. 



    What we know: Our cells have an innate antiviral ability. When a virus is present in our bodies, our immune system notices and responds, limiting the virus’s entry into our cells and its replication. This innate process should lead to a controlled cell death (called apoptosis) of the infected cells, thereby stopping or slowing infections. Unfortunately, our immune systems have weakly responded to the COVID-19 coronavirus in this way, leading to high infection rates and mortality.  


    What the researchers found: When CBDA and CBGA were combined with the COVID-19 viral proteins, they were better able to activate the immune system, leading to apoptosis. The researcher also found that CBDA helped “prime” the body to better respond to the virus even before exposure without harming normal cells. This suggests that CBD may have a role in SARS-CoV-2 prevention.  


    Notably, the research was performed in vitro, meaning in a petri dish and not on humans (in vivo). The doses of CBDA and CBGA delivered were high but achievable for human consumption at non-toxic doses. Further work is needed to determine how the virus/CBD combination is altered when CBD is present and at what dose. 


    This week, another study funded by the National Institutes of Health and the University of Chicago was published in Science Advances journal that looked at CBD’s effect on live cells, or in vivo. These researchers found that CBD and its metabolite 7-OH-CBD, could potentially block the SARS-CoV-2 virus from replicating in the lungs of infected mice, representing a possible therapeutic treatment once people are infected with the virus.  


    This study also reported that a review of SARS-Co-V-2 infection rates in over 1000 patients treated with high quality CBD for epilepsy (tracked by the National COVID Cohort Collaborative) found that these patients, who were given CBD twice daily in an oral solution of 100 mg/ml, were more likely to test negative for COVID-19 compared to their counterparts who recorded no use of CBD. 


    In summary:   More clinical trials, particularly in vivo, are needed. Patients should not forgo currently accepted treatments for COVID-19/ SARS-CoV-2 based on the findings above. But this data should spur more studies. Future research may provide data to support an excellent and markedly safe option to treat and prevent COVID-19 and other viral infections using the cannabis plant.  



    Cannabinoids Block Cellular Entry of SARS-CoV‐2 and the Emerging Variants 

    Richard B. van Breemen,* Ruth N. Muchiri, Timothy A. Bates, Jules B. Weinstein, Hans C. Leier, Scotland, Farley, and Fikadu G. Tafesse 


    Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune response 

    Long Chi Nguyen, et. al. 


    MoCannTrade's Health Education & Training committee researches & defines best practices with stakeholders (healthcare systems, physicians, providers and patients) to ensure a safe, responsible and successful medical cannabis program implementation. The healthcare committee also works to accomplish education and training, sensible regulatory development, CME credit seminars, thought leadership, speaking engagements and patient advocacy.